The gene expression array method enables us to achieve expression profiling with thousands of genes. Clinically resected bulk cancer tissues, however, contain not only cancer cells but also stromal cells, which may affect gene expression profiling and hamper
The recent advent of the gene expression array method allows us to investigate expression profiling with thousands of genes. It may be of great use for molecular analysis of clinical specimens as well as of cultured cells. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] However, clinically resected bulk cancer tissues contain not only cancer cells but also diverse kinds of stromal cells, eg, fibroblasts, lymphocytes, and vascular endothelial cells. Such cells may affect the gene expression patterns of profiling and prevent accurate analysis of gene expression in cancer cells per se. Therefore, a procedure for selective dissection of specific cells, such as laser capture microdissection (LCM), 11, 12 will be needed for the clinical application of expression profiling. There have been a few reports describing the combination of the LCM method and the gene expression array method. [13] [14] [15] However, the studies did not compare the gene expression pattern obtained using RNA extracted from cancer cells by LCM with that obtained using RNA merely extracted from bulk cancer tissues. Using operatively resected endometrial cancer specimens, we first demonstrated the difference in the expression patterns between the 2 methods (LCM method and bulk tissue method), without any amplification procedures such as polymerase chain reaction (PCR) or T7 polymerase reactions. 13, 15 In addition, differential expression analysis between tumor and nontumor tissue yielded quite different profiling between the 2 methods. from operative specimens of 3 patients (EC1, EC2, and EC3) who underwent hysterectomy. Immediately after hysterectomy, a few pieces of tissue, 5 × 5 × 5 mm, were excised from the endometrial cancer tissue of all 3 patients and from the adjacent normal endometrial tissue of patient EC1 with careful attention to avoiding contamination by ribonuclease. These pieces were frozen in liquid nitrogen as rapidly as possible and stored at -80°C until performance of LCM or extraction of RNA.
The histologic diagnoses of EC1, EC2, and EC3 were serous adenocarcinoma and endometrioid adenocarcinoma grade 1 and grade 2, respectively.
Laser Capture Microdissection
For microdissection, a piece of frozen tissue was cut into 10 to 20 serial sections with a thickness of 10 µm, and sections were mounted on uncoated glass slides and stored at -80°C. For a histologic diagnosis, one section was stained with H&E by the standard method. Before LCM, sections were fixed in 70% ethanol for 1 minute, followed by stepwise dehydration with 95% ethanol twice and 100% ethanol twice for 1 minute each, and incubation in xylene for 1 minute. After air drying of the sections, target cancer cell nests were delineated with markers on the monitor and selectively microdissected from the section according to the standard laser capture procedure 11,12 using a PixCell II LCM system (Arcturus Engineering, Mountain View, CA/Olympus, Tokyo, Japan). For patient EC1, 2.0 × 10 5 normal endometrial cells also were dissected from the normal endometrial tissue to permit analysis of the differential expression between tumor and nontumor tissue.
RNA Preparation
Laser-captured cell nests, which were transferred to a film, were placed on the top of a tube containing 100 µL of Isogen (Nippongene, Toyama, Japan) and mixed briefly for lysis. All Isogen solutions were collected into 1 tube (1-2 mL in total), and total RNA was extracted according to the manufacturer's protocol and stored in 70% ethanol at -80°C. During this step, glycogen was added to facilitate the RNA precipitation. The residual piece of frozen bulk tissue (cancer or normal endometrium) was ground in liquid nitrogen with a chilled mortar and pestle and was homogenized in a Potter glass homogenizer. After adding 1 mL of Isogen, total RNA was similarly extracted and stored in 70% ethanol at -80°C.
Expression Array Method
Synthesis of the complementary DNA (cDNA) probe and its hybridization to an expression array membrane were performed using the Atlas Human Cancer 1.2 Array system (Clontech, Palo Alto, CA), basically according to the manufacturer's protocol. Briefly, for the synthesis of the cDNA probe, all of the total RNA obtained from the endometrial cancer cells or the normal endometrial cells by LCM was reverse transcribed by Superscript II (Gibco BRL, Gaithersburg, MD) in the presence of 35 mCi of phosphorus 32 alpha-labeled deoxyadenosine triphosphate ([alpha-32 P]-dATP; Amersham Life Science, Arlington Heights, IL) and the CDS primer mixture (Clontech) provided with the system. As for RNA prepared from bulk tissue, 2 µg of total RNA was used for the synthesis of cDNA probes. Then the synthesized probes were purified with a CHROMA SPIN-200 DEPC-H 2 O column (Clontech), denatured, mixed with Cot-1 DNA, and added to ExpressHyb (Clontech). An expression array membrane, prespotted with 1,176 cancerrelated genes (retrievable on the Web at http://www.clontech.com/index.html), was hybridized with the probes overnight at 68°C. Then the membrane was washed 4 times in 2× sodium chloride/sodium citrate (SSC) containing 1% sodium dodecyl sulfate (SDS) at 68°C for 30 minutes each, in 0.1× SSC containing 0.5% SDS at 68°C for 30 minutes, and in 2× SSC at room temperature for 5 minutes.
Analysis and Comparison of Expression Array
A phosphorimaging plate (Fuji Imaging Plate; Fuji Film, Tokyo, Japan) was exposed to the hybridized membrane for a time that depended on the signal intensity obtained with a test exposure for 24 hours. Then the plate was scanned using the Fuji BAS 2500 system (Fuji Film). Detection and quantification of signals were performed with Image Gauge Software (Fuji Film). The signal intensity of each gene was represented as the actually measured signal intensity minus the background signal intensity. The values were further normalized by the mean signal intensity of 5 stably expressed housekeeping genes. For comparison of gene expression between 2 membranes, the signal ratio of each gene corresponding between the 2 membranes was calculated and represented in pseudocolor images including 9 stepwise colors (red to green) by the application of Excel 98 software (Microsoft, Redmond, WA). When the ratio of the signal intensity of a gene to background signal intensity (S/N ratio) was less than 1.5 on both membranes, it was represented as gray and excluded from analysis.
Results

Microdissection and Expression Arrays
Fresh tissue samples of endometrial cancer and/or normal endometrium were obtained from 3 patients. LCM was performed to dissect target cell nests (glands) from frozen tissue sections ❚Image 1❚. Cell nests were distinctly punched out of the sections and attached to a transfer film One tissue section was prestained with H&E for histologic diagnosis and for orientation during dissection (A and D). The cell nests were punched out (B and E) and transferred to a film (C and F). LCM was carried out using tissue sections without any staining procedure to minimize the damage to cellular RNA. (A, H&E, ×100; B, ×100; C, ×100; D, H&E, ×150; E, ×150; F, ×150) (Images 1B, 1C, 1E, and 1F). We dissected approximately 2,500 to 10,000 cells per section and a total of 0.5 × 10 5 to 2.0 × 10 5 cells from 10 to 20 serial sections per specimen.
In preliminary experiments, the total amount of RNA obtained by LCM (corresponding to around 1.0 × 10 5 cells) ranged from 0.8 to 1.2 µg, which was near the lower limit for synthesis of cDNA probes with our system. Therefore, we used all of the RNA obtained by LCM, without any amplification procedures such as PCR or T7 polymerase reactions, to synthesize the maximum amount of cDNA probes labeled with (alpha-32 P)−dATP. We hybridized the synthesized cDNA probes to a membrane on which cDNAs for 1,176 cancer-related genes were prespotted ❚Image 2❚. The overall signal intensity in LCM method was comparable to that in the bulk tissue method.
Comparisons of Expression Arrays
As for patient EC1, expression arrays were created in duplicate independently using RNA from bulk cancer tissue and using RNA from cancer cells obtained by LCM (B, B' and L, L', respectively). The signal ratios of B to B' (B/B' ratio) and that of L to L' (L/L' ratio) were calculated for respective genes and were expressed by pseudocolor imaging (the 2 left columns in ❚Figure 1A❚ through ❚Figure 1D❚). Genes with an S/N ratio of less than 1.5 on both compared membranes, which seemed to be inappropriate for a comparison, were expressed as a gray cell. There were 947 and 858 genes with color other than gray, which were possible to compare, in the B/B' and L/L' columns, respectively. Of these, the genes with a B/B' and an L/L' ratio ranging from 0.5 to 2 (expressed as a black cell) accounted for 97.0% (919/947) and 96.3% (826/858), respectively, indicating the high reproducibility of both expression array methods.
To compare the gene expression profiling between the array created by using RNA from cancer cells obtained by LCM (LCM method) and that created by using RNA extracted from bulk cancer tissue (bulk tissue method), the signal ratio of the former to the latter (L/B ratio) was calculated for respective genes and was expressed by pseudocolor imaging, as in the L/L' and B/B' ratio, for all 3 patients (the right 3 columns in Figure 1A-1D ). There were 986, 828, and 721 genes with a color other than gray in patients EC1, EC2, and EC3, respectively. Of these, the genes with an L/B ratio ranging from 0.5 to 2 accounted for 74.3% (733/986), 80.3% (665/828), and 59.9% (432/721) in the respective patients, indicating that the expression patterns differed between the LCM method and the bulk tissue method in contrast with the high reproducibility within the same methods.
There were 76 genes with an L/B ratio of less than 0.25, expressed as greenish cells, among all 3 patients ( Figure 1A-1D ). It is notable that 8 of these genes belonged to the geneprotein group of immune system proteins (upper part in Figure 1D , enlarged in ❚Figure 1E❚), including subunits of lymphocyte antigen and immunoglobulins (IgG, IgA). The other 68 genes belonged to diverse gene-protein groups and presumably originated from various components of the stromal cells.
On the other hand, there were 40 genes with an L/B ratio of more than 4, expressed as reddish cells, among all 3 patients ( Figure 1A-1D) . Nine of them belonged to the geneprotein group of transcription factors (lower part in Figure  1B , enlarged in ❚Figure 1F❚), including subunits of NFkappaB and signal transducer and activator of transcription 3. The other 31 genes belonged to diverse gene-protein groups and presumably originated from various components of the cancer cells.
Differential Expression Analysis
We also undertook differential gene expression analyses between tumor and nontumor tissues in patient EC1 using the 2 expression array methods (LCM and bulk tissue). The signal ratio of each gene for the tumor/nontumor ratio was calculated based on the data from each array method and was plotted ❚Figure 2❚. As a result, surprisingly, the tumor/nontumor ratios distributed quite differently between the methods. This seems to have been caused synergistically by the influence of the stromal cells in tumor and in nontumor tissue (Image 1A and Image 1D).
Discussion
Gene expression profiling with the availability of a cDNA array method is a powerful technique for simultaneous analysis of expression by thousands of cellular genes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] This high throughput method is reliable when it is used for a homogeneous sample such as cultured cell lines, 1,2,5-10 and it is expected to be applicable to genetic examination of clinical specimens such as cancer. However, it goes without saying that clinically resected cancer tissue contains not only cancer cells but also various kinds of stromal cells, which may prevent accurate analysis of gene expression profiling of cancer per se. LCM is a sophisticated method to dissect target cells from complex tissue microscopically, 11, 12 and the combination of LCM and a cDNA array method may circumvent the problem of the complexity. In the present study, we demonstrated the difference in gene expression profiling when LCM was used or not used and confirmed the importance of this combination for clinical specimens. The quantity of RNA obtained by LCM was rather small (0.8-1.2 µg from 1.0 × 10 5 cells), despite the lengthy procedure. However, we did not use any enzymatic amplification procedures such as the PCR or T7 polymerase reaction, 13,15 because we sought to linearly quantitate the gene expression by the LCM method and the bulk tissue method to make the data proportional to data from Northern hybridization or dot blot hybridization. In this context, we think the present data are reliable and can be referred to as basic data when evaluating the other expression profiling methods.
Genes encoding immune system proteins were expressed more strongly in the profiling obtained from bulk cancer tissue without LCM. This result may be accounted for by the general fact that bulk cancer tissue contains infiltrating lymphocytes, where such genes are expressed. Indeed, the cancer specimens examined in the present study contained a relatively rich stromal area microscopically (36%, 30%, and 37% in patients EC1, EC2, and EC3, respectively) with moderate lymphocyte infiltration (Image 1A). Although the ratios of stromal area (cell) were diverse in individual tumors, for a ratio at least more than 30%, LCM is necessary for gene expression profiling according to our results. However, if the ratio of stromal cell is sufficiently small, for example, in hepatocellular carcinoma, LCM may not necessarily be required, although we did not confirm that in the present study. Besides immune system proteins, there were 68 genes that were expressed more strongly in the profiling obtained from bulk cancer tissue were basically according to a manufacturer's guide (Web site: http://www.clontech.com/index.html) with slight modifications. E and F, Enlarged images of the gene-protein groups for immune system proteins (E) and transcription factors (F) were shown. The individual immune system genes with an L/B ratio of less than 0.25 (E) and the individual transcription factor genes with the L/B ratio of more than 4 (F) were denoted. CDK, cyclin-dependent kinase; GDP, guanosine diphosphate; GTP, guanosine triphosphate; IgGK, immunoglobulin kappa chain constant region; IgG1K, immunoglobulin kappa heavy chain. without LCM. Although most of them could be expressed in both cancer cells and stromal cells, it is speculated that predominant expression in stromal cells was attributable to such seeming difference, as in the case of the immune system proteins. On the other hand, there were 40 genes that were expressed more strongly in the profiling obtained by the use of LCM. These genes were thought to be up-regulated in cancer cells theoretically, and such up-regulations were observed mainly in patient EC1 with serous adenocarcinoma, which is the most aggressive type of endometrial carcinoma associated with rapid progression of disease and a poor prognosis. Nine of the genes belonged to the gene-protein group of transcription factors, which have a pivotal role in the exertion of various functions for malignant transformation. Therefore, there is a possibility that specific expression of genes that actually were up-regulated in cancer tissue would have been underestimated unless LCM had been used.
We performed differential expression analyses between tumor and nontumor tissue and obtained quite different patterns in expression profiling when LCM was used and when it was not used. This result might be due to the enhanced errors caused by stromal cells that existed in both tumor and nontumor tissue. Thus, the LCM method is indispensable for a differential expression analysis. Nontumor tissue, which is paired with tumor, may not be necessary as a control in expression profiling since cultured cells are available as a stable and universal reference. 9 The microdissection method is considered to be essential for bona fide gene expression profiling of clinically resected cancer. The combination of LCM and gene expression profiling will help us obtain the information about the characteristics of individual tumors, which will be useful for determining individualized cancer therapy. To obtain an accurate result, an experienced pathologist or a trained cytologist should carry out the dissection since cancer cells must be strictly discriminated from surrounding stromal cells and normal epithelial cells. It takes a few hours to obtain a sufficient number of cells for the synthesis of cDNA probes.
